Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GS-9901 is a selective, orally active and potent PI3Kδ inhibitor (IC50: 1 nM) for the study of non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 146.00 | |
5 mg | In stock | $ 358.00 | |
10 mg | In stock | $ 645.00 | |
25 mg | In stock | $ 986.00 | |
50 mg | In stock | $ 1,350.00 |
Description | GS-9901 is a selective, orally active and potent PI3Kδ inhibitor (IC50: 1 nM) for the study of non-Hodgkin's lymphoma and chronic lymphocytic leukemia. |
Targets&IC50 | PI3Kδ:1 nM |
In vivo | In female Lewis rats with established collagen-induced arthritis (CIA), GS-9901 (0.3 mg/kg, 1 mg/kg, and 3 mg/kg; orally, twice daily for 7 days starting on the 10th day after the second collagen immunization) significantly reduced ankle swelling[1]. |
Molecular Weight | 477.88 |
Formula | C22H17ClFN9O |
CAS No. | 1640247-87-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 120 mg/mL (251.11 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GS-9901 1640247-87-5 PI3K/Akt/mTOR signaling PI3K GS 9901 GS9901 inhibitor inhibit